← Leaderboards
Edward Benjamin Thorp
Northwestern University
$11,579,385
Attributed
$13,584,507
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,584,507 · 8
By mechanism
R01$10,498,968 · 4
R35$1,091,824 · 1
T32$1,079,733 · 1
R00$733,982 · 1
K99$180,000 · 1
Top collaborators
- Xunrong Luo5 shared
- Matthew Joel Feinstein2 shared
Most similar at Northwestern University
Same institution · by research overlap
- Harris R Perlman$22,048,932
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationMacrophageCellsMolecularMonocyteImmunePathway InteractionsAcuteInsightResolutionCardiacClinically RelevantProteolysisCell DeathApoptoticResistanceMorbidity - Disease RateRepairedMertk GeneCessation Of LifePhagocytesMetabolicLinkSignal Pathway
Grant awards (30)
Phagocyte Crosstalk in the Balance of Inflammation & Cardiac Disease$1,091,824
R35 · FY2025 · HL · contact PI
Integrated epidemiology of systemic and plaque-specific immunologic features of human atherosclerosis$788,083
R01 · FY2025 · HL
Immunology and Molecular Pathogenesis Training Program$363,421
T32 · FY2025 · AI · contact PI
Integrated epidemiology of systemic and plaque-specific immunologic features of human atherosclerosis$796,083
R01 · FY2024 · HL
Efferocytosis-Directed Inflammation Resolution and Repair in the Hypoxic Heart$682,846
R01 · FY2024 · HL · contact PI
Contributions of Myeloid Metabolism to Diastolic Dysfunction$504,422
R01 · FY2024 · HL · contact PI
Immunology and Molecular Pathogenesis Training Program$364,704
T32 · FY2024 · AI · contact PI
Efferocytosis-Directed Inflammation Resolution and Repair in the Hypoxic Heart$550,408
R01 · FY2023 · HL · contact PI
Contributions of Myeloid Metabolism to Diastolic Dysfunction$514,716
R01 · FY2023 · HL · contact PI
Immunology and Molecular Pathogenesis Training Program$351,608
T32 · FY2023 · AI · contact PI
Efferocytosis-Directed Inflammation Resolution and Repair in the Hypoxic Heart$550,408
R01 · FY2022 · HL · contact PI
Contributions of Myeloid Metabolism to Diastolic Dysfunction$514,716
R01 · FY2022 · HL · contact PI
TAM-Kinases in Transplant$628,468
R01 · FY2021 · HL · contact PI
Efferocytosis-Directed Inflammation Resolution and Repair in the Hypoxic Heart$550,408
R01 · FY2021 · HL · contact PI
TAM-Kinases in Transplant$627,837
R01 · FY2020 · HL · contact PI
Efferocytosis-Directed Inflammation Resolution and Repair in the Hypoxic Heart$564,908
R01 · FY2020 · HL · contact PI
TAM-Kinases in Transplant$565,512
R01 · FY2019 · HL · contact PI
TAM-Kinases in Transplant$38,749
R01 · FY2019 · HL · contact PI
TAM-Kinases in Transplant$565,512
R01 · FY2018 · HL · contact PI
Efferocytosis Directed Inflammation Resolution and Repair in the Hypoxic Heart$386,250
R01 · FY2018 · HL · contact PI
Efferocytosis Directed Inflammation Resolution and Repair in the Hypoxic Heart$407,989
R01 · FY2017 · HL · contact PI
Efferocytosis Directed Inflammation Resolution and Repair in the Hypoxic Heart$451,468
R01 · FY2016 · HL · contact PI
Efferocytosis Directed Inflammation Resolution and Repair in the Hypoxic Heart$380,456
R01 · FY2015 · HL · contact PI
Efferocytosis Directed Inflammation Resolution and Repair in the Hypoxic Heart$43,479
R01 · FY2015 · HL · contact PI
Efferocytosis Directed Inflammation Resolution and Repair in the Hypoxic Heart$386,250
R01 · FY2014 · HL · contact PI
Efferocytosis in CVD & Inflammation$236,341
R00 · FY2013 · HL · contact PI
Efferocytosis in CVD & Inflammation$248,641
R00 · FY2012 · HL · contact PI
Efferocytosis in CVD & Inflammation$249,000
R00 · FY2011 · HL · contact PI
Efferocytosis in CVD & Inflammation$90,000
K99 · FY2010 · HL · contact PI
Efferocytosis in CVD & Inflammation$90,000
K99 · FY2009 · HL · contact PI